Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

11.1K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.1K
Drug Accumulation During Multiple Dosing: Repetitive IV Injections01:21

Drug Accumulation During Multiple Dosing: Repetitive IV Injections

256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

243
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
243
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

223
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
223
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Molecular Structures: Investigating Demographic Factors in Drug-Induced Cardiotoxicity Prediction Models.

Journal of chemical information and modeling·2026
Same author

Molecular deep learning at the edge of chemical space.

Nature machine intelligence·2026
Same author

Machine learning for biomolecular modeling.

The Journal of chemical physics·2026
Same author

"<i>Visualize</i>, <i>Describe</i>, <i>Compare</i>"─Nanoinformatics Approaches for Material-Omics.

ACS nano·2026
Same author

Automated navigation of condensate phase behavior with active machine learning.

Nature communications·2025
Same author

Enhancing deep chemical reaction prediction with advanced chirality and fragment representation.

Chemical communications (Cambridge, England)·2025

Related Experiment Video

Updated: Jan 18, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K

Going beyond SMILES enumeration for data augmentation in generative drug discovery.

Helena Brinkmann1, Antoine Argante1, Hugo Ter Steege1

  • 1Institute for Complex Molecular Systems (ICMS), Eindhoven AI Systems Institute (EAISI), Department of Biomedical Engineering, Eindhoven University of Technology Eindhoven The Netherlands f.grisoni@tue.nl.

Digital Discovery
|September 8, 2025
PubMed
Summary

Novel data augmentation techniques for small molecular datasets improve generative deep learning. New methods like atom masking and token deletion enhance de novo molecule design, especially in low-data scenarios.

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

616

Related Experiment Videos

Last Updated: Jan 18, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.2K
Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

616

Area of Science:

  • Computational Chemistry
  • Machine Learning
  • Drug Discovery

Background:

  • Small molecular datasets limit generative deep learning models.
  • Data augmentation, particularly SMILES enumeration, is crucial for de novo molecule design.
  • Existing SMILES augmentation methods may not fully exploit chemical and linguistic information.

Purpose of the Study:

  • To investigate novel SMILES augmentation techniques for enhancing de novo molecule design.
  • To introduce and evaluate new strategies inspired by natural language processing and chemistry.
  • To expand the toolkit for designing molecules with specific properties in data-scarce environments.

Main Methods:

  • Developed four novel SMILES augmentation strategies: token deletion, atom masking, bioisosteric substitution, and self-training.
  • Applied these methods to small molecular datasets for generative deep learning.
  • Systematically analyzed the performance and advantages of each strategy.

Main Results:

  • All introduced SMILES augmentation strategies demonstrated potential for improving de novo design.
  • Atom masking proved effective for learning physico-chemical properties in low-data regimes.
  • Token deletion showed promise in generating novel molecular scaffolds.

Conclusions:

  • Rethinking SMILES augmentation techniques can significantly enhance generative deep learning for molecule design.
  • The developed strategies offer distinct advantages for addressing limitations of small datasets.
  • This expanded repertoire provides chemists with more powerful tools for designing molecules with bespoke properties.